Skip to main content
. 2016 Mar 8;15(Suppl 1):28. doi: 10.1186/s12940-016-0105-4

Fig. 7.

Fig. 7

Estimated prevalence of West Nile Virus infections in the blood donor population (per 100,000) by districts for 2014 (a) and for 2025 (b). Note: The prevalence of infection in the (donor) population was calculated based on the European Up-Front Risk Assessment Tool (EUFRAT) developed by ECDC [49]